DUPIXENT® Now PBS Listed for Atopic Dermatitis

3 Mar, 2021 | News

DUPIXENT is now listed on the PBS for patients 12 years and older with severe atopic dermatitis who have had an inadequate response to topical corticosteroids.

Learn how to assess your patients for PBS eligibility

Sign up HERE 

Attachment

For further details click here

More Latest News…

Melanoma and Skin Cancer Nurse Symposium

Melanoma and Skin Cancer Nurse Symposium

Melanoma Institute Australia is delighted to invite you to an engaging educational symposium designed specifically for nurses with an interest in skin cancer medicine. Developed by nurses, for nurses, this engaging one-day symposium brings together leading...

read more
Webinar: Updates in management of non-melanoma skin cancer

Webinar: Updates in management of non-melanoma skin cancer

Melanoma Institute Australia invites you to register for their free webinar for Skin Cancer GPs, General GPs and Nurses. Hosted by Skin Cancer GP, A/Prof Paul Fishburn, this engaging webinar will feature leading multidisciplinary experts sharing the latest updates on...

read more